Cargando…
Multi-biomarker panel signature as the key to diagnosis of ovarian cancer
Early detection of ovarian cancer has been a challenge to manage the high mortality rate caused by this deadly disease. The trends in mortality have been reduced by the scientific contributions from the corners across the globe, however accounting for the fifth leading cause of gynecological mortali...
Autores principales: | Muinao, Thingreila, Deka Boruah, Hari Prasanna, Pal, Mintu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906658/ https://www.ncbi.nlm.nih.gov/pubmed/31867451 http://dx.doi.org/10.1016/j.heliyon.2019.e02826 |
Ejemplares similares
-
Biosensors based detection of novel biomarkers associated with COVID-19: Current progress and future promise
por: Pal, Mintu, et al.
Publicado: (2022) -
Editorial: Trends of microbial technologies in rehabilitation of contaminated environments
por: Deka Boruah, Hari Prasanna, et al.
Publicado: (2023) -
Platelet protein biomarker panel for ovarian cancer diagnosis
por: Lomnytska, Marta, et al.
Publicado: (2018) -
Editorial: Multi-omics approaches in cancer research with applications in tumour prognosis, metastasis and biosensor based diagnosis of biomarkers
por: Pal, Mintu, et al.
Publicado: (2023) -
Multi-Omics Analysis Identifying Key Biomarkers in Ovarian Cancer
por: Li, Ju-Yueh, et al.
Publicado: (2020)